Testing ACOU085 to prevent hearing loss from cisplatin chemotherapy
Part of Cancer, Ear, nose & throat clinical trials.
This trial tests a new drug called ACOU085 to prevent hearing loss in men with testicular cancer who are receiving cisplatin chemotherapy. If you meet the hearing and health criteria, you may be able to join and help see if this drug can protect your hearing.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a man between 18 and 45 years old with testicular cancer.
- You are scheduled to receive cisplatin chemotherapy (a total of at least 300 mg/m² over 3 cycles).
- You have normal hearing in both ears and no history of ear problems or hearing loss.
- You are not taking any other medications that could damage your hearing.
- You agree to use effective contraception (if you have a female partner) for 6 months.
- You are willing to follow the study procedures and sign a consent form (in German).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how cisplatin chemotherapy affects hearing and balance in people with head and neck cancer. It compares those getting cisplatin-based treatment to those getting only radiation. The goal is to better understand and potentially reduce these side effects.
This study compares how patients’ quality of life changes when people who have hearing loss from platinum chemotherapy use a hearing aid versus not using one. It may help understand whether hearing aids improve daily life during treatment.
This trial tests whether adding Pedmark (sodium thiosulfate) to cisplatin chemotherapy can protect hearing in men with stage II or III testicular germ cell tumors. It aims to reduce the risk of drug-related ear damage while still treating the cancer.
This Phase 2 trial tests whether sodium thiosulfate and mannitol can reduce hearing damage (ototoxicity) in adults receiving cisplatin chemotherapy. It may help protect hearing while you get cancer treatment.
This Phase 2 trial tests whether a cholesterol medicine called atorvastatin can protect hearing in people with head and neck cancer receiving cisplatin plus radiation. If it works, it may reduce the chance or severity of treatment-related hearing damage.
This trial tests if taking N-acetylcysteine (NAC) can help prevent hearing loss caused by high-dose cisplatin chemotherapy. If you're getting cisplatin and are between 18 and 70, you may be able to join.
Hear when a new Cisplatin-induced Hearing Loss trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.